Can antibiotic prescribing for respiratory infections be reduced?

Martin Gulliford and Mark Ashworth
Med J Aust 2017; 207 (2): . || doi: 10.5694/mja17.00382
Published online: 17 July 2017

It must be — as an essential component of the response to the antimicrobial drug resistance problem

The growing threat of antimicrobial drug resistance (AMR) is attracting the attention of national governments and international organisations. In the words of Margaret Chan, Director-General of the World Health Organization, “We are hearing one alarm bell after another.”1 This is apparent in primary care, where the frequency of antibiotic-resistant infections is increasing. The emergence of AMR is a multifaceted societal problem that requires action from a range of actors, including the pharmaceutical, agricultural and food production industries.2 But it is the health care sector, where antibiotics are prescribed and patients with resistant infections are seen, that the impact of AMR is most acute. This is especially relevant in Australia, where antibiotic consumption is among the highest of the OECD countries.3

  • Martin Gulliford
  • Mark Ashworth

  • King's College London, London, United Kingdom


Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.